Seres Therapeutics Inc

NASDAQ:MCRB   3:59:52 PM EDT
5.91
-0.12 (-1.99%)
Products

Seres Therapeutics Announces Completion Of Rolling BLA Submission To FDA For Investigational Microbiome Therapeutic Ser-109 For Recurrent C. Difficile Infection

Published: 09/07/2022 11:32 GMT
Seres Therapeutics Inc (MCRB) - Seres Therapeutics Announces Completion of Rolling Bla Submission to FDA for Investigational Microbiome Therapeutic Ser-109 for Recurrent C. Difficile Infection.
Seres Therapeutics Inc - Anticipated Product Launch in First Half of 2023.